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 1 
Abstract 
 
The main goal of this work is the development of a computational framework 
capable of designing and numerically simulating a new biodegradable medical 
device for cardiovascular and respiratory applications. This framework needs to be 
parametric since the geometry of the new device should be susceptible to be 
changed depending on the selected application. The new stent should be printable 
with the 3D printing technique with a biodegradable material to be chosen. This 
work is a part of the regional project PC086-087-088 CONDE financed by the 
Department of Economic Development of the Navarra Government. For designing 
the new device, two typical stent typologies have been used: Mesh-W and Mesh-T. 
Additionally, squared and circular sections have been tested for the stent strut. As 
parameters for the device, the strut thickness, the stent diameter and length, the 
length and the number of repetitive elements within a single stent unit-cell have 
been chosen. The main idea of the work is that, once a parameter is changed, all the 
design, computational mesh and boundary conditions will simultaneously actualize 
for allowing a new numerical simulation. The latter is necessary for estimating the 
radial compression of the device that is the most important feature of the device. 
Two biodegradable material have been selected: the PCL that has been 
characterized with a linear elastic material behavior and a Magnesium alloy (AZ31) 
that has been characterized using an elastic-plastic material. The main parameters 
that have been changed are the stent diameter (5 to 18 mm), the single unit-cell 
length (2 to 3 mm) the strut thickness (0.3 to 0.5mm) and the number of unit cell 
repetitions. As a conclusion, the computational framework is capable of designing, 
analyzing and characterizing the device with the constraints and the requirements 
of the project as for example the 3D printing and the biodegradable material to be 
chosen.  
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Chapter 1 
 
 
 
INTRODUCTION 
 
 
 
1.1 Stent definition  
 
A stent is a cylindrical structure in wire mesh, which is introduced into blood 
vessels and it is made to expand until its diameter is equal to that of the lumen. 
 
 
1.2 Clinical background  
 
From the most recent data of Global Health Observatory (2016), can be seen how 
the incidence of the cardiovascular disease is the most important death cause in the 
world. From the below figure, where are presents the incidence rate of the first ten 
causes of death in the world, is clear that ischemic heart disease gets the most 
important role. 
In particular, in the year 2016 the first ten death causes killed 56.9 millions of 
people, which correspond at the 54% of the entire world deaths, and of these 15.2 
millions of deceases, are caused for the first death cause, the ischemic heart one. 
The trend is the same from the last 15 years. Is difficult collect this type of data, 
mostly in the poor countries and in this case are estimated. They are very important 
for the countries, because in this manner they can fix new politics to improve the 
health of the people. 
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            Figure 1 – Global Health Observatory (GHO) data (2016) 
 
 
 
Only in the United States of America every year are implanted over than 1.8 million 
stents and, of these, approximately 965000 are used in the coronary applications. 
The remaining are for peripheral vascular implantation.  
This data gives the importance of the development of the devices, which can help 
the medicine procedures to improve the technique to resolve this kind of problem 
in the society. In the last 30 years, from when was invented and applied the first 
stent (1986), there was a high impulse on the research groups to improve the 
characteristics of these devices. In a stent, there are many fields in which its possible 
to work to obtain a better device, but some of these are limited by the needs 
imposed, for example, by the material chosen, by the realization technique, by the 
design selected and by the application site.  
The realization process of the stent is not so easy and for each case is necessary to 
design a new device. This is one of the most important problems in the stent 
productions. In this manner, it is difficult adapt one device to a different site from 
the cardiovascular one. The application range is important, because the stents could 
be used for all the organs which have a lumen. This generalization is the objective 
of this work. The innovation of the work will improve the stent realization process 
and the simulation testing part of these devices.  
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The guidelines at which all the companies watch to realize a useful device, contain 
the following features: 
 
• Excellent flexibility and manageability 
• High radial stiffness 
• Shape such as the vessel  
• Safe anchorage  
• Radiopaque  
• Patient specific  
• Biocompatibility 
 
1.2.1 Blood vessel  
 
Is important to understand how is composed a typical blood vessel where the 
new device could be implanted. The artery wall is composed by three concentric 
layers: 
 
1. The inner layer is the intima. It is positioned on a very thin thickness of 
connective tissue which is constituted by elastic fibers forming an inner 
elastic lamina; 
2. The media layer which can be made mainly by elastic tissue in the artery 
with a large diameter, or by smooth muscular tissue in the artery with a 
medium or small diameter. The first are named elastic type arteries and 
the latter the muscular ones; 
3. The external layer, named Tunica externa or adventitia is made by 
connective tissue and between this layer and the intermediate one is 
present an elastic external lamina. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44 – Artery composition 
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1.2.2 Endothelial tissue 
 
The endothelial tissue is a particular type of connective tissue, deriving from the 
mesenchymal one, which cover the internal wall of the blood vessel. The 
endothelial cells which compose the tissue are plane, polygonal and stretched to 
the blood flow. The apical face is oriented towards the vessel lumen and the 
nuclei are in the same direction. The cells contain a small number of elements 
such as Golgi apparatus, mitochondria, endoplasmic reticulum and ribosomes. 
An elevated number of pinocytosis vesicles for the transport through the 
endothelium wall and the electro-dense granules of Weibel-Palade which are 
present also in the platelets, are contained in the cytoplasm of the cells. In the 
granules membranes is present the P selectin which is inside the Willebrand 
coefficient which is the factor eight of the coagulation. The endothelial tissue 
has a very important role in the coagulation process, in fact is able to interact 
with the proteins involved in the healing process and with the blood cells. The 
secretion done by the endothelial cells can inhibit the thrombosis and the 
hyperplasia of the intima, which is the excessive growth of the smooth muscular 
cells causing the obstruction of the vessel lumen and are essential to guarantee 
the homeostasis and the maintenance of the vessel integrity. The application site 
of the secreted elements is different. In fact, the paracrine secretion happens near 
the cell for influence the vasal wall, but the endocrine secretion is in the flow 
and develop its function far from the cells, having functions such as the 
regulation of the blood pression. The endothelial tissue has a fundamental role 
in the remodeling, which is observed in the hypertension, in the stenosis after 
the angioplasty and in the atherosclerosis. Also, is important in the coagulation 
modulation and in the interactions between the blood cells, the platelets and the 
leucocytes. Moreover, the tissue is influenced by the mechanical signals deriving 
from the blood flow and by the neuro-hormonal signals deriving from the 
vasoactive mediators and has a control function of the arteries and the micro-
flow. Two mechanical forces can be provoked by the blood flow on the vessel 
wall: the shear stress and the tensive stress. The first is caused by the friction of 
the blood flow on the vessel wall and influences only the epithelial cells, instead 
the latter is caused by the hydrostatic pression in the vessel and interested the 
endothelium, the fibroblasts and the smooth muscular cells. The shear stress 
causes the liberation of the vasodilators factors and the tension stress influence 
the vessel contraction. The net effect is the combination between the two 
phenomena. The studies for this behavior of the endothelium tissue were done 
by Holtz in the 1983.  
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1.2.3 Angioplasty: Surgical procedure 
 
The surgical procedure used for the implantation of the stents is the Angioplasty. 
This is a minimal invasive technique. The first time was realized in 1977, by the 
German surgeon Gruntzig. The surgical procedure has a duration of about 1 
hour. The angioplasty is performed under local anesthesia: the patient is 
therefore awake and conscious. The catheter, which contain the stent and a 
balloon, is insert from the percutaneus puncture of an artery, usually femoral 
artery or radial artery, and is carried up to the stenotic vessel. When it arrives in 
the correct position, the balloon that is present inside the stent, is inflated and the 
device restores the normal diameter of the vessel and the improvement of the 
blood flow. The medical device, thanks to its features will remain in situ and, at 
the end, the catheter will be removed and the surgical procedure end.  
 
 
 
 
 
 
 
 
 
 
                                        
      Figure 2 – Angioplasty procedure 
 
 
The plaque, which blocked the vessel, is pushed to the wall sides, but is not 
eliminated. After four months from the intervention, there is the complete 
endothelization that means that the device is full covered by the cells of the inner 
part of the vessel. There are several consequences after a stent deployment. One 
of these problems is the phenomenon called Restenosis and it is the partial 
obstruction of the vessel: in fact, the tissue grows up also between the mesh of 
the stent and can decrease the diameter of the lumen until the thirty percent.  
 
 
 
 
 
 
 
 
 
                                     
    Figure 3 – Restenosis after stent application 
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The life of a metallic stent is typically of 20 years during which, unfortunately, 
the artery tends to re-occlude and cause slowly the usefulness of the device. The 
Bypass technique permits to avoid the obstruction connecting the healthy part of 
the blood vessel using a part of an artery or a vein (for the first one is used a tract 
of internal thoracic artery, and for the second one a tract of Safena vein taken 
from the leg of the patient). The procedure is done with the heart stopped, using 
the heart-lung machine, or with the beating heart.  
 
 
               Figure 4 – Bypass example 
 
 
It is important to remember that the application field of these devices is not the 
cardiovascular one but is also possible to use for Trachea applications, as for examples. 
In this work we focus on the Cardiovascular field, but in the future will be investigated 
also the tracheal one.  
 
1.2.4 Biodegradation  
For the aforementioned reasons, is would be of a great advantage that the stent 
disappears after complying its mission. In the last decades, new devices with a 
variety of materials have been developed with this aim. In particular, the 
biodegradable materials have been introduced as alternative of traditional 
metallic stents. The temporal presence of the stent avoids the long-term 
problems of the non-degradable devices such as fatigue struct fracture, in-stent 
restenosis and late stent thrombosis. Unfortunately, if this process is not 
controlled, could bring problems for the patient health. In fact, the healing 
process approximately persist for 6-12 month. Hence, its necessary, that the 
device maintain its mechanical properties at least for this period. Theoretically, 
if the degradation process works properly, at the end could be the increasement 
of local alkalization or hydrogen generation, etc. After the healing period, the 
stent would disappear degrading itself into non-toxic and non-inflammatory 
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products that are readily soluble inside the human body, without influencing the 
closed tissues. 
 
1.3 Biomaterial and Biocompatibility  
 
A biomaterial is a substance used for the construction of devices able to substitute 
a living part situated in the human body. This is a generic description of the word, 
but in the last years was perfectioned by the researchers. The first definition of 
biomaterial was proposed in the 1974, at the 6th Annual International Biomaterials 
Symposium and presented the “Biomaterial as an inert substance for the organism 
and also for the pharmacologic point of view, designed for the implant or the 
incorporation in a living system” [1]. Now, the last recent version of the definition 
is correlated with the operative and functional approach. Actually, “a biomaterial is 
synthetic substance projected to be used for a long time in contact with biological 
elements, minimizing the damage reactions caused by the organism”. An important 
condition which the materials must have is the biocompatibility that is “the ability 
to determine, from the living system, a positive reaction when it is placed inside the 
human body, for a specific application” [2].  
 
Since the ancient time, were present a lot of examples of biomaterial applications. 
The first was in the Egyptian era where the artificial prothesis were made of wood. 
The metallic materials were used for the first time during the American civil war. 
A famous episode was the utilization of a nail to fix a femoral fracture of a soldier. 
From that moment there was a development in the material research which 
permitted the utilization of stainless steels, metallic alloys, ceramics and polymers 
for the realization of the devices.  
 
The biomaterials history can be summarized into three fundamental parts: 
 
• First biomaterials generation is that which has the feature of minimizing the 
physics and chemical interaction between the material and the organism. 
• Second biomaterials generation: the substance is bioactive which means that 
there is a rapid integration of the material with the organism that implies the 
formation of bonds and interactions with the physiological fluid, or 
resorbable, if the material is degraded by the living system, without damage 
or toxic effects for the organism.  
• Third biomaterials generation: the material has to be bioactive and 
resorbable. The research, now, is following this direction. 
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The last category of biomaterials presented are also named biomimetics, because 
are able to interact with the tissues through process of biomolecular recognition 
mechanisms.  
 
Is important to know that the biomaterials are also classified by their chemical 
nature into: 
 
• Polymerics 
• Metallics  
• Composites 
• Ceramics 
 
 
1.4 Stent 
 
In the world market there are a lot of typologies of stent, characterizing for the 
presence and the absence of: 
 
• a particular structure of the section 
• a certain design 
• made with a particular category of materials. 
 
In the following, the two main types of stent will be presented, including their 
materials and characteristics. Also, the two designs selected for this work will be 
introduced and discussed in detail. 
 
1.4.1 Non-biodegradable stents  
The first category presented in this work is occupied by non-biodegradable 
stents. Typically, these devices are made with metallic materials (BMS). They 
were used for the first time in 1987 [3] and their utilization is considered the 
second revolution in interventional cardiology [4]. The stents are made of 
stainless steel (316L), nickel-titanium and cobalt-chrome alloys, which are 
widely used in the arterial diseases. After the healing time usually occurring 
between 6-12 months, the metal stents remain permanently located in the arterial 
vessel of interest, though it becomes unnecessary. Its presence usually causes 
complications, as in-stent restenosis, subacute thrombosis, tissue inflammation 
and risk of loosening and fracturing, caused by long periods of cyclic loading of 
the stent [5][7]. Nevertheless, these devices have a good biocompatibility and 
mechanical properties and give sufficient scaffolding to the target arteries [5]. In 
the table below are summarized the features of this first stent category: 
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Table 1 – Non biodegradable stent characteristics 
 
 
 
In the following section, will be presented the principal stents of BMS category, 
present in the global market. 
 
 
1.4.1.1 Examples of non-biodegradable stents 
 
Zilver Flex stent  
The Zilver® vascular stent is a self-expanding device made of Nitinol. Its 
intrinsic mechanical properties allow an excellent flexibility. Its shape is as a 
slotted tube, which is projected to provide support, while maintaining 
flexibility in the vessel upon deployment. After the application, the stent is 
designed to impart an outward radial force upon the inner lumen of the vessel, 
establishing patency in the stented region. The shape of the mesh is “W 
named” and it has a square section. The device is available in different sizes 
for the diameter and the length.  
 
 
 
 
 
 
 
 
 
 
 
 
 
CHARACTERISTICS 
• High radial 
stiffness 
with a very 
thin 
thickness 
• Average 
life of 15-
20 years 
• Neo-intima 
hyperplasia 
formation 
• Stent 
thrombosis 
• In-stent 
restenosis 
• Metallic 
material 
formation 
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Figure 5 – Zilver Flex® vascular stent 
 
 
Innova stent 
The Innova™ Vascular Self-Expanding Stent is produced by the Boston 
Scientific company. The device is a laser cut self-expanding stent made of a 
nickel titanium alloy (Nitinol). On both the proximal and distal ends of the 
device, radiopaque markers made of tantalum are present to increase visibility 
of the stent to aid in placement. The Innova™ stent has a very similar design 
to that of the Wallstent™ and it appears as its evolution. In fact, the main 
difference is that the initial and the final ends of the Innova™ are closed, 
instead those of the Wallstent™ are open. The Innova™ stent has a circular 
section and the shape of the mesh is “W named”. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
            Figure 6 – Innova™ vascular stent 
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Acculink stent 
The RX Acculink Carotid Stent System is produced by Abbott. The device 
permits a high coverage to reduce embolic risk. There are both the straight 
and tapered stent options. It is made by Nitinol material which gives strength, 
crush resistance, conformability and flexibility. The stent is indicated for the 
treatment of patients at high and standard risk for adverse events from carotid 
endarterectomy who require carotid revascularization and meet the criteria 
outlined below. The device is not indicted for the patient which suffers 
hypersensitivity to nickel-titanium. 
 
  
 
 
 
 
 
 
 
 
 
 
           Figure 7 – Acculink Carotid Stent 
 
 
 
 
1.4.2 Biodegradable stents 
The second category is that of the Biodegradable Stent (BDS). The scientists 
noticed that the permanence in the human body of the BMs device was not safety 
for the patient and for this reason the research went towards a way. BDS is 
considered to be the fourth revolution in interventional cardiology. [4] The 
biodegradable devices support the vessel inner wall for a limited period of about 
4-6 months. After the healing period, the vessel will be healed and reorganized, 
while the biodegradable stent will be degraded and absorbed [4]. The vessel, 
after the disappearance of the BDS, is left free from foreign devices in the site 
where the disease was, thus there will be the retrieval of the vaso-reactivity with 
the potential of vessel remodeling [8]. Using BDS leads the vascular restoration, 
which is a great benefit because preserve the physiological integrity of the 
vessels, the long-term positive remodeling and the reactive vasomotion [9]. The 
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principal materials used to make the BDS are classified in two groups: the 
polymeric or the metallic ones. In the table below are summarized the features 
of the second category of stent presented: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 – Biodegradable stent characteristics 
 
 
1.4.2.1 Biodegradable polymeric stents 
The polymeric materials are widely used in the medical treatment. A common 
example is the Collagen, which is employed from a lot of time. The research 
into biomedical applications of synthetic degradable polymers started only in 
the 1960s [10]. These materials present a very useful intrinsic properties, as 
the ability to be broken down and resorbed without removal or surgical 
intervention. The biodegradable polymers present a number of advantages 
over other materials for realizing devices. The main advantages are connected 
with the degradation time which is possible to adapt it to the different 
applications, modifying some parameters. In addition, the principal 
advantages in their utilization are good biocompatibility, low coefficients of 
 
 
 
 
 
 
 
 
 
 
 
 
CHARACTERISTICS 
• Low presence of in-
stent restenosis 
Low stent 
thrombosis 
• Fast degradation  
• High radial 
stiffness, but with a 
greater thickness 
than the metallic 
one  
• Made of metallic 
alloys or of 
polymeric materials  
• degradation into 
non- toxic product 
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friction, easy processing and workability, ability to change chemically and 
physically the surface, and ability to immobilize cells or biomolecules within 
them or on the surface [11]. The synthetic biodegradable polymers most uses 
in the clinical application and the stent production are poly (glycolic acid), 
poly (lactic acid) and their copolymers, poly (p-dioxanone), and copolymers 
of trimethylene carbonate and glycolide. 
 
1.4.2.1.1 Examples of biodegradable polymeric stents 
 
Igaki-Tamai stent 
 
The Igaki-Tamai stent is a biodegradable coronary stent. The two doctors, 
who invented this device, worked, for the realization, at Kyoto Medical 
Planning. It was the first biodegradable device applied in human body and 
the clinical studies started more than twenty years ago, or rather in 1998. 
But only from 2007 it is commercially available. Its design is “W named” 
and is made of a high molecular weight (321KDa) PLLA. The complete 
degradation occurs more of three years after the surgical procedure. The 
struct thickness of the device is 0.17 mm. it expands a certain temperature 
and there is no coating. The Studies showed the effectiveness, the 
feasibility and the safeness of the stent. The evolution of the Igaki-Tamai 
stent was implemented from the 2007 and it is used for the treatment of 
blood vessels in the lower extremities and it is known with the Remedy™ 
name. 
 
 
 
 
 
 
 
 
 
 
                                           
                                                         Figure 8 – Igaki-Tamai vascular stent 
 
Absorb bioresorbable vascular scaffold 
The Absorb Bioresorbable Vascular Scaffold (BVS) (Abbott, California) 
is a biodegradable stent that will fully resorb and is used to improve the 
vessel luminal diameter in patients with ischemic heart disease. The device 
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is made by poly (L-lactide) (PLLA) and it has a coating layer made by 
poly (D, L-lactide) (PDLLA) which is used to facilitate the release of 
drugs. The stent has a “W named” mesh, it has two platinum radiopaque 
markers and it is expanded with the balloon technique.  
The device can be used only for the vessels, which have the diameter of 
2.5 mm and 3.75 mm. 
 
 
 
 
                                                  
                                Figure 9 – Absorb Bioresorbable vascular scaffold 
 
 
Reva stent 
 
The REVA stent (REVA Medical, California, USA) is a medical device, 
made of biodegradable polycarbonate polymers derived from naturally 
occurring tyrosine amino acid. The bonds of iodine are covalent for 
radiopacity. The device, also, has the function to restore the natural vessel 
motion in one year and the complete resorption is with benign degradants. 
As all the other device, it provides strength during vessel healing period. 
The Reva stent has a struct thickness of 0.2 mm, which permits a safe 
expansion for the device and the function to gives the adequate radial 
force.  
 
 
 
 
 
                                                          
                                                     Figure 10 – Reva stent 
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1.4.2.2 Biodegradable metallic stent 
The biodegradable metallic stent is the last way that the researchers are 
investigating with the objective to obtain the best device for the surgical 
applications. Biodegradable metals are defined as metals, which corrode 
gradually in vivo, with a proper host response induced by the products 
deriving by the corrosion, then, after the healing period, are absorbed with no 
implant residues [12]. Now, the materials most investigated are magnesium 
(Mg) and Iron (Fe) based alloys, but the studies are oriented on the 
magnesium. The biodegradable Mg alloys appear as the suitable biomedical 
degradable materials. Firstly, this type of materials is dissoluble in aqueous 
solutions, mostly in those where are contained chloride ion electrolytes, since 
of their very low corrosion potential [13]. Secondly, the Young’s modulus of 
the bone tissue (15-20 GPa) is close to that one of the magnesium alloy 
(45GPa). Those of the stainless steel and of the Nitinol are very different. For 
this reason, the stress shielding effect is avoided. Thirdly, the Mg cation is 
one of the essential elements in the human body and the fourth most abundant. 
The daily quantity of Mg intake in a health adult person is 300-400 mg and 
greater amounts of this element are harmlessly and efficiently excreted in the 
urine [14]. But this element has a limitation in the degradation. In fact, Mg 
has a very high corrosion rate and commonly this involve the degradation 
before the healing period end. To improve the resistance to the corrosion can 
be used: 
• alloys; 
• particular structure design; 
• surface modification. 
These are the technique which gave the manner to solve this limitation.  
 
1.4.2.2.1 Examples of biodegradable metallic stents 
Dreams stent 
The DREAMS stent is an evolution of the AMS device, produced by the 
Biotronik company. The AMS stent was the first biodegradable stent 
produced by the company. It was made for the 97% by Mg and for the 7% 
by rare earth metals.  The improvements that are present in Dreams 
biodegradable device are essentially four:  
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• now is used a Mg alloy with a slower resorption and a higher 
collapse pressure; 
• the struct thickness is reduced; 
• there is the changing between rectangular to square structs; 
• is added an antiproliferative drug-eluting polymeric coating. 
Actually, the resorption time is augmented from 2 months of the AMS 
device until 9-12 months of this one. There are two generation of the stent. 
In the first, the coating layer has a thickness of 1 µm. In the second 
generation, are improved the design, which gives to the device a great 
radial stiffness comparable to the metallic stent and received the CE mark 
in the 2016 [15]. 
 
 
 
 
 
Figure 11 – Ams vascular stent, 1st generation 
 
 
 
 
 
 
 
    
 
 
 
                                                             
 
Figure 12 – Dreams vascular stent, 1st generation 
 
 
 
 
 
 
 
 
 
                               
Figure 13 – Dreams vascular stent, 2nd generation 
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1.4.3 Stents available on the market 
 
In the table 3, it is possible to see all the stent available on the world market. The 
table allows a general view of the devices for a better visual comparison of the 
design and of the material (identifiable only from the color).  The principal stents 
and the most interesting for the features are been described before. There is a lot 
of work to do in the research field to obtain a better device which could help the 
medicine to improve the ischemic disease treatment. Possible and necessary 
improvements are also responsible of the stent companies, as did the Biotronik 
company for the Dreams devices.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 – Stents available 
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1.5 Mesh design  
 
In the world market, the devices, which have more success, because have better 
mechanical properties, have two typologies of mesh structure: The type-T and the 
type-W. 
The starting point in the development of the new device was to take the most 
improved design presents in the literature.  The idea was to use these designs as 
base for the new improvements which give better mechanical properties to the 
stents and permit the fabrication of the devices. The software used was SolidWorks 
and all the design possible were limited from the constraints deriving from the 
method used for their production.  
 
 
 
 
 
 
 
 
 
 
 
    
                      Figure 14 – W mesh                                  Figure 15 – T mesh 
 
 
 
1.6 Struct 
 
Studying the literature and searching in the world market is clearly possible to 
notice how the favorite shapes for the realization of a stent are the type-W and the 
type-T configurations. The W mesh design presents a W trend between a certain 
number of wires that run through all the device. In the market, there are a lot of 
variations for the positions of the support poles in the stent but is always possible 
to recognize the two fundamental parts, which compose the device: The W trend 
and the support poles. Where the geometry is more complex, there will be more 
tension in the compression studies. The T mesh design is similar to a wire wrapped 
mesh. The dimensions of the holes and the thickness of the wires can be changed. 
Another interesting think is that the ends of the device can be open or close. In fact, 
the choice between the two different configurations could influence the healing 
period, in that these determinates the contact between the device and the tissue and 
the blood flow through the vessel. In the new devices the direction is to use a closed 
shape of the border meshes, and almost all the devices presented follow this trend. 
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                                               Figure 16 – Square section 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 – Circular section 
 
 
 
 
1.7 Fabrication methods for biodegradable stents 
 
Typically, for the fabrication process of the stents two main approaches are 
possible: The first one is the bottom-up, where the technique provides an additive 
process of the material deposition, starting from a solid support. This technique is 
used from 3D (dimensional) printing and from solvent casting techniques. The 
second one is the Top-down process, instead, is a subtractive technique usually 
starting from material blocks and removing all the unnecessary pieces to obtain the 
desired shape. Laser machining, molding and electroforming use these typologies 
of process. 
 
3D printing technique in the last years has become one of the most used production 
processes. In fact, it presents a lot of advantages and, in the engineering field, is 
also used to fabricate tissue scaffolds, because exploits the dispensing based rapid 
prototyping technique. The advantages include the ability to adapting to a widely 
scale of materials, from liquid to solid paste, the great repeatability, the good 
precision and control over microstructure and the simple production condition, such 
as no high temperature, no toxic solvent needed and efficient and rapid fabrication 
process. The 3D printing technique is widely used for the realization of 
biodegradable stent, not only for polymeric ones, such as made by PCL, PLLA and 
PLA, but also for which made by metallic biodegradable materials, like based on 
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magnesium alloy. There are also some disadvantages but are all connected with the 
minimum thickness limit that is possible to imprint.  
 
Fused deposition molding (FDM) is a particular production technique, where the 
object is made by the repetitive deposition of thin material layers, such as polymeric 
one, which create the 3D object. Moreover, the melt spinning technique is used for 
polymeric fibers with the thickness included between 150 to 200 µm, which then 
can be woven or knitted into stent devices. The fabrication process described is new 
and further studies are necessary for a better knowledge of this technique and to 
improve the process. A limitation is due to the obstacles caused by the melting 
points of the materials. 
 
Injection and compression molding processes are very indicated for the polymeric 
materials for their intrinsic thermoplastic behavior. The recent development is 
oriented in the optimization of micro and Nano molding processes. The ICM 
technique combines the injection and compression molding processes. The 
advantages of this technique are in the increasing of the micro-surface precision 
and the reduction of the flow distance/wall thickness ratio. Is difficult to obtain a 
perfect process because problems, such as the melt penetration to the parting line 
caused by late compression or incomplete filled caused by early compression, could 
happen.  
 
Laser machining is the widely used method generally for metallic stents. The 
technique is formed by two parts, or rather the formation of the tube and the cutting 
phase, done by the laser which gives the desired meshes to the device. This process 
has a high resolution. Also, an advantage is the ability that the laser machining has, 
is possibility to gives complicated structure and design at the stent with a so high 
accuracy. In the other side, the process requires a lot of time and for the 
biodegradable polymeric materials is not recommended, because the heat, produced 
in the process, could damage the physical and chemical properties of the material 
and the covalent bonds between the atoms and molecules. This technique was used 
to the production of the biodegradable polymeric Reva stent.  
 
In the table 4 the advantages and the disadvantages of the fabrication techniques for 
the production of biodegradable stents described above are reported. 
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Fabrication    
Technique 
 
 
Advantages 
 
Disadvantages 
 
3D printing 
technique 
 
• High 
efficiency 
• Low cost  
• Noddle 
diameter 
limitation 
 
Fused 
deposition 
molding 
(FDM) 
• Fast 
fabrication 
• High 
precision 
• Control 
production  
 
• Heat effects 
• Noddle 
diameter 
limitation  
 
 
Injection and 
compression 
molding 
processes 
 
• Fast 
production 
• Low cost 
 
• Design 
restriction 
• Difficulty  
 
Laser 
machining 
 
• High 
resolution  
• High 
accuracy  
 
• Heat effects  
• Incompatible 
for all the 
materials 
 
 
Table 4 – Fabrication technique and properties  
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1.8 Motivation aim and scope 
 
The main goals of the master thesis work are the development of a computational 
framework capable of designing and numerically simulating a new medical device. 
This tool needs to be parametric to be used for several applications and to be patient 
specific.  
Moreover, the present work is an improvement in the stent realization process for 
the following aspects: 
 
• Specificity of the device for the patient 
• Avoid of time consuming in the realization 
• Wide application range 
 
In addition, the stent should be fabricated with a biodegradable metallic alloy of 
Magnesium. Finally, it should be 3D printable. The collaboration between three 
companies for the realization of this project led at the division of the research fields. 
In fact, the UPNA (Universidad Publica de Navarra) is in charge of the design and 
of the computational testing such as, the simulation of the compression test studies 
for determining the radial strength. The AIN (Asociación de la Industria Navarra) 
is in charge of assembling the necessary materials of the device, and NAITEC 
(Centro Tecnológico de Automoción y Mecatrónica de Navarra) will perform the 
experimental tests and the biodegradation process. In the following chapter the 
workflow and the correspoding software used for each step done for creating the 
computational tool are described. 
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Chapter 2 
 
 
 
MATERIALS, INSTRUMENTS AND METHODS 
 
 
In this chapter the materials analyzed and used in this master thesis work, with their 
features and the motivation for the choice done will be presented. Moreover, the 
descriptions of the software used for the design and the simulation parts, with the 
presentation of the tests carried out and the motivation of the meaning of the 
simulations are exposed. How described in the first chapter, the new stents will be 
designed with the two most typical struts geometrical organization such as T-mesh 
and W-mesh. 
 
2.1 Materials 
 
The material used for the realization of this project is based on Mg. The composition 
of the alloy is made by the AIN company. The materials used for the simulation 
tests and for the realization of the first samples has different physical properties. 
 In fact, one has a linear-elastic behavior and the second has an elasto-plastic 
conduct. The first used, the linear-elastic, belong to the polymeric materials and it 
was the Polycaprolactone (PCL). The latter, and closer to the definitive one, was 
the Magnesium alloy AZ31.  
The idea for choosing the material is to select one with an elasto-plastic behavior. 
This because the plastic behavior is important for the position of the stent in a vessel 
and because using this kind of material is impossible that the device could move 
along the vessel. But, the analysis of the differences between two kind of behavior 
give a complete definition of the scene and permit to do very important 
considerations. In the last chapter, the analysis of the compression tests and the final 
consideration about the designs and the material compositions of the stents will be 
presented and discussed. 
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2.1.1 Polycaprolactone  
 
The polycaprolactone (PCL) is a biodegradable synthetic semi-crystalline 
polymeric material. In the biomedical field it is widely used for its high thermal 
stability. Moreover, it presents a chlorine, oil, water and other solvents 
resistance. The PCL is made by polymerization with ring opening, using as 
catalyst agent the stannous octanoate. The polycaprolactone has a melting 
temperature including between 59-64 °C and a glass transition temperature close 
to -60°C. This is very low compared to other bioabsorbable polymers, used for 
biomedical applications. The decomposition temperature is 360°C. The 
degradation process of the PCL is the hydrolysis, because the polycaprolactone 
has ester bonds within the molecule structure. Was observed that the polyester, 
after two years from the implantation, present a significant decrease of the 
molecular weight, highlighted by the decreasing of the relative viscosity of the 
order of 80-90%. 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 – PCL molecular structure 
 
 
The behavior in the stress-strain test is linear-elastic. In particular, for this 
reason, there is no residual deformations or plasticity problems. But this not 
eliminates the breaking point that will be present with a particular value of stress. 
The stress values are in the Megapascal (MPa) range and the strain have not the 
measure unit, because is described as the ratio between the deformation minus 
the initial length of the sample, divided for the initial length. 
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Figure 19 – elastic-linear behavior of the PCL 
 
In the following table, are summarized the principal properties of the material 
used for the devices with the relative values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 – PCL physic characteristics 
 
 
Material Characteristics: 
 
 
Density: 
 
 
1440.8 Kgm^-3 
 
Young’s 
Modulus: 
 
 
400 Mpa 
 
Poisson’s 
Ratio: 
 
 
0.33 
 
Bulk 
Modulus: 
 
 
3.9216 E+08 Pa 
 
Shear 
Modulus: 
 
 
1.5038 E+08 Pa 
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2.1.2 Magnesium Alloy AZ31 
 
The Magnesium Alloy AZ31 is a biodegradable alloy made of 3% Aluminum, 
1% Zinc, 0.05% Copper, 0.04% Calcium, 0.02% Manganese, 0.01% Silicon, 
0.005% iron and 0.005% nickel. Alloy is a monophasic or polyphasic mixture, 
constituted of two or more elements of which at least one, the principal, is 
metallic and its name is base metal. The AZ31 alloy is produced by the Norsk 
Hydro ASA (Oslo, Norway), with a particular technique called Twin Roll 
Casting. This involves direct continuous casting inside two counter-rotating and 
water-cooled cylinders. Today, the magnesium alloys are studied in the 
biomedical device research field. In fact, the high presence of the Mg inside the 
human body allows the realization of instruments made by this material. The 
mechanical behavior of the Magnesium AZ31 alloy is elasto-plastic. In fact, if 
we consider only the stress values under 120 MPa, it is possible to see an elastic-
linear behavior. The loading and un-loading processes follow the same straight 
line. But when we increase the stress value the behavior of the material become 
plastic. In fact, the two phases of loading and un-loading in the tests follow 
different paths. In the end, remain a residual deformation which transform the 
sample from the initial one. It is not possible return to the initial configuration 
of the specimen, if the force applied is reduced in the way it was increased. These 
mechanical behaviors changes with the temperature values. But from the 
medicine studies the body internal temperature and the material properties are 
known. It is also possible to notice this trend observing the figure below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
Figure 20 – elasto-plastic behavior of the Magnesium AZ31 
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It is important to know that higher is the stress force, higher will be the residual 
deformation. Augmenting the force at a specific level the rupture will be 
reached. In the following table, the principal properties with the relative values 
are summarized. 
 
 
 
Material characteristics: 
 
 
Density: 
 
 
1770 Kgm^-3 
 
Young’s 
Modulus: 
 
 
44.8 Gpa 
 
Poisson’s Ratio: 
 
 
0.35 
 
Yield Strength: 
 
 
138 MPa 
 
Ultimate Tensile 
Strength: 
 
 
245 MPa 
 
 
Table 6 – AZ31 physic features 
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2.2 Work flow 
 
For the realization of the projects two software are used: SolidWorks and Ansys. 
The first was utilized to create the design of the stents and to parametrized it. In 
fact, with this technique, the device is able to change some important parameters, 
allowing changes in its geometry and dimensions. The parametric designs of the 
two mentioned stent types were imported in the Workbench of Ansys in which the 
computational radial tests were performed. 
 
2.2.1 SolidWorks  
 
SolidWorks is a solid modeling computer-aided design (CAD) and a computer-
aided engineering (CAE) computer program. The software permits the 
realization of 2D and 3D geometries. The company was founded in 1993 by the 
Massachusetts Institute of Technology. The first version of the program was 
released in the 1995 and now the last one is the “SolidWorks 2019” that are 
present in the market from the October 2018. The approach to the project can be 
top-down or bottom up. The SolidWorks program is a solid modeler which 
utilizes a parametric feature-based approach. In fact, it is important to know that 
the parameters refer to constraints whose values define the geometry of the 
project or the assembly. The parameters can be numerical and/or geometrical: 
the first are line lengths or circle diameters and the second, are the bonds of 
parallel, horizontal, vertical, concentric, tangent or coincidence. It is possible to 
associate one numeric parameter with another simply using relations, that allow 
them to capture the design idea. The design idea is to permit the optimization of 
the device according to the needs. It is possible with SolidWorks to specify what 
are the parts which can be modified changing also one parameter. The features 
are connected with the building blocks of the part. They are the operations and 
the shapes of which the part is composed. Shaped-based features start with a 2D 
or 3D sketch of the desired shapes and then these are extruded or filled with the 
addition or the diminution of material.  
In the present work, the parametric part connected with the software was very 
important. In fact, all the measures of the devices implemented are connected to 
seven fundamental parameters. Changing the value of one of them, there is the 
actualization of the stent design and consequently the characteristics of the 
device respond to the requisites deriving from its application. As an example, it 
could be possible to generate patient specific devices. In the program, is possible 
to change the parameters opening a particular window and varying the desired 
parameter.  
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Once the designs are ready, these can be imported into the commercial package 
Ansys. In the Workbench tool of Ansys, the computational process 
corresponding to the conventional finite element modelling can be performed. 
The different tools of Ansys allow the generation of the computational meshes 
and the definitions of the material modellings and boundary conditions.  
The great advantage of the parametric tool is that when a geometrical parameter 
changes in SolidWorks will have a consequent effect on the finite element 
model: once the design changes, the computational model will be consequently 
updated. Since the designs realized can be subjected to considerable changes due 
to the industry requirements, the created framework represents a useful tool for 
managing the development of a new device that is the main goal of the work.  
 
2.2.2 Ansys  
 
Ansys (Ansys Inc., Canonsburg, PA, USA) is an engineering simulation 
software based on the finite element method which was invented by John 
Swanson in 1970. In the 1993, the founder sold the company and from the 1996 
is listed on the Nasdaq. From the 2000, the industry bought another society 
expanding the engineering knowledge in fluid dynamic, electronic design and 
physic analysis fields. The Ansys software was invented and product as a finite 
element analysis program employed for the simulation of engineering problems.  
The program permits the additional creation of structures or machine/electronics 
components to tests the strength, toughness, elasticity, temperature distribution, 
electromagnetism, fluid flow, and other characteristics in a simulation level. The 
objective of the program is to identify and quantify how a device will work with 
different conditions, without the real construction of tests products or conducting 
crash tests. A clear example could be the realization of a new instrument with a 
new design and less material without sacrificing the safety. The majority of the 
simulation applications are done with the Ansys Workbench, which is one of the 
most famous software of the company. Also, the present work is realized using 
this software. Moreover, Ansys users divides larger structures into small 
components that are modeled and tested individually. Finally, is possible to start 
by defining the dimensions of a device and then adding force, temperature, 
pressure, weight, etc.  
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2.2.3 Ansys Workbench  
 
The ANSYS Workbench environment is an intuitive up-front finite element 
analysis tool that is used in connection with CAD systems and/or Design-
Modeler. ANSYS Workbench is a program for simulating structural, thermal, 
and electromagnetic analyses. In the present Master thesis Work, the utilization 
of the Workbench involves the static structural part. In the block of the tests, are 
present the following parts, which have to be completed in order to perform the 
analysis: 
 
• Engineering Data 
• Geometry 
• Model  
• Setup 
• Solution 
• Results 
• Parameters 
 
Engineering Data is important in the definition of the material components. In 
fact, opening this field, the material parameters can be defined. Is also possible, 
to upload the mechanical behavior curve of the element (stress/strain curve) and 
the material features of the device will adapt to the one loaded. In the engineering 
data section are present a wide material list where is possible to select the one 
desired. In figure 21, the main window presents in the left all the mechanical 
behaviors which is possible to select. Choosing, example “isotropic elasticity”, 
a second window will open, and it will be possible to complete the fields in it 
with the more adequate values. In the upper part, the main material categories 
are presents and, in the right one, the mechanical curve with the set parameters 
is showed. 
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Figure 21 – Engineering data 
 
 
Geometry is one the most important field of the static structural analysis. In fact, 
the geometry of the device has to be uploaded and the software has to show 
correctly all the its parts. The measures have to be adequate and not always happen. 
The geometry of the device can be directly implemented in the workbench or can 
be imported from other design software, such as SolidWorks. For the latter, two 
different uploaded ways are possible. Firstly, the SolidWorks project with the  
“. IGES” is saved and the Workbench will read the file in the geometry section. 
This choice does not permit changes in the device structure and to modify the 
project it is necessary to update the instrument measures in the design software, re-
save the project with the extension and then re-upload in the workbench. All the 
border conditions have to be reset. The second is to connect the design program, in 
this case SolidWorks, directly with the Ansys Workbench software, as did in the 
present work. In this manner, all the modifications do in the device structure are 
automatically imported and actualized in the workbench geometry part. The border 
conditions, in the model part, are actualized without doing anything. At the 
beginning, to implement the second manner is more difficult than to use the first, 
but then there are advantages. 
  
 
 
 
 
 
 
 
 
 
Figure 22 – design import process 
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Model is the part of the test definition which is more complex and long to obtain. 
After the geometry importation, the first step is to define the coordination 
system. In fact, the software gives a default system, but is possible to change it 
and to move the application place of the system. Moreover, it can have more 
than one coordinate system, such as the absolute and the relative ones, and it can 
be chosen between the cartesian, polar and cylindrical systems. The second step, 
if there are contact regions is the selection of contact typology and the solution 
method used in that region, such as MPC, Augmented Lagrange. The following 
step is the mesh definition. This is a very important step which can influence the 
final results. In fact, ad adequate number of elements has to be selected for a 
specific model. However, a very high number of elements, i.e. a very high 
number of elements promotes high computational costs while a low number of 
elements has limited costs. Hence, it has to be found a compromise between the 
precision necessity and the computational cost. After the implementation of the 
mesh size, the program will report the number of elements created with the 
dimension used and the number of nodes. The Workbench offers the possibility 
to choose between three shape types of mesh: triangle, tetrahedron and pyramid. 
The software permits the creation of named selections which are useful in the 
force application in the testing part and are important in the definition of the 
nodes orientation when are present curve structures. 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 23 – different mesh dimension examples 
 
 
 
 
Setup part there are all the border condition such as the force and/or movements 
which the testing object can undergo. In fact, to analyzing a particular device 
behavior under the force application or under a controlled deformation it is 
necessary to set all the parameters. Moreover, it has to be selected if the object 
can have a linear or nonlinear behavior, the solution method which is used to 
arrive at a solution, if the convergence or the deformation have to be controlled 
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or forced, and all this parameter are mentioned only for the static structural 
analysis typology. In fact, in this part there are the Analysis Settings panel, where 
are to be imposed the Step Controls and the Solver Controls and then the fixed 
supports, the displacement and/or the forces applied, their intensity values, the 
coordinate reference system, the place where are applicated and the orientation. 
In the Workbench software an applications menu, where can be selected the 
desired feature and when one of these is chosen, a new window is open with all 
the parameters which have to be inserted is present. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 24 – Ansys Workbench configuration 
 
 
 
Solution and Results in the simulation test processes it is necessary to understand 
how the device react to the imposed conditions. In fact, the software permits to 
analyze the data coming from the test and visualizing the results obtained. In the 
solution part, the user has to select what it is important to check, the coordinate 
system in which wants to see the solution, in what part of the instrument to 
observe the results, the observation time and which variable need to be exported. 
Is also possible to apply an augmenting or decrementing force/displacement. In 
the same time, the program offers the possibility to see some different features 
and for each one gives the numerical data, a visual overview under a movie shape 
and the maximum, the minimum and the average value measured. Also, all the 
data can be downloaded and automatically the software prepares a written 
relation, where are present all the parameters and the solution methods used to 
obtain the results. Moreover, is possible to save on the program the data and the 
configuration prepared. The visual part, because is immediately understand what 
the problems in the configuration are, where the device presents higher tensions 
and how to change the simulation setup is very important. 
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Parameters could be change when start the tests and all the features are correctly 
present. The workbench offers the possibility, in the model configuration, to 
select a number of parameters which can be modify from the blocks window 
without changing the border conditions of the entire simulation test. This 
increases the velocity in the process and contributes to automatize all the analysis 
part. In this manner, it is always possible to control the process and avoid trivial 
errors. 
In the block diagram is present a section called “parameters” where these are 
located in a scheme the selected ones with their own values. Is also possible to 
insert a certain number of parameters deriving from the solution data and so that 
they can be elaborated and analyzed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25 – Ansys Workbench blocks diagram 
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2.2.4 Matlab  
 
The software used for the calculation of the force and for the graphic 
representation was MATLAB (Matrix Laboratory). In fact, this software was 
used for the analysis part and for the comparisons of the obtained results. 
MATLAB is a multi-paradigm numerical computing environment and 
proprietary programing language. It permits the matrix elaboration, plotting 
data, realization of algorithms, implementation of user interfaces, and 
communication with programs developed in other languages, such as C, C++, 
Java, Python. Essentially, the utilization of MATLAB was concentrated in the 
realization of the arrays structures to represent the data and the calculation of the 
Normal Force, which is the value analyzed in the compression and dilatation 
studies. The version used in the work is the R2017b, which is adequate for the 
analysis. Now is possible to download the license for the last one, which is the 
R2019a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 – Matlab interface 
 
 
The upper figure shows the typical Matlab interface. Is possible to see the main 
blocks which compose it: 
 
• Script is the part where is usually written the code. In fact, the only way 
to save the coding part is to write on it.  
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• Command window is also used to write the code but cannot be saved. Is 
also the place where are indicated the eventually errors when the code is 
controlled, before to execute the program. 
• Workspace is the place where all the variables are indicated with their 
respective values. 
• Current folder indicates the working ambient were the user is coding and 
in what folder the progress will be saved.  
 
 
To verify the program the user has to press the bottom “Run” and if the function 
provides a figure, it will appear in a new window which can be modify with a 
lot of function.   
 
 
2.2.5 3D printing technique 
 
The two devices design and described are produced by the Naitec company with 
the 3D imprinting technique. The realization process consists in: 
 
• Saving the design file with the “. STL” extension  
• Sending the data to the NAITEC company 
• The company controls the stent design and their printing method 
• NAITEC gives limitation and possible issues deriving from the 
fabrication process 
 
To research the best way to fabricate the stents, the files contain two version of 
the devices. In fact, the stents were designed in a 3D and in a plane version. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 – Files “. STL” of the two version of the same stent typology 
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The realization process tried to use all the two ways to obtain the devices with 
the best resolution and precision. The fabrication of the device, for the first draw, 
was with a bottom-up strategy. This one provides the material deposition from a 
support, which at the end will be removed. The advantage of the approach is the 
realization of the device, without weak points, that are present if it is necessary 
to merge the stents in some parts of it. Unfortunately, some issue arises due to 
the resistance, because as layers build up, the inferior part has to be solid and to 
stand the increasing weight. For this the deposition velocity has to be controlled 
and the design has to be optimized. NAITEC studied and determined the 
adequate parameters for the realization of the stents. The second strategy, 
provides the 3D printing of the stent in a plane way and then to close it, obtaining 
the circular shape. Certainly, the latter technique is faster than the first one, 
permits the realization of particular design, but the presence of the merging 
section can influence the physical and chemical properties of the device.  
At the end, for the realization process of the devices, was used the first technique, 
that influenced the devices design, but permitted to have the best precision and 
resolution as described before. In the figure below, there is a representation of 
the 3D imprinting machine, but in this case the layers deposition occurs in the 
horizontal direction, and with the utilization of a support cylinder [16].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 – 3D imprinting technique  
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2.3 Methods  
 
In the present section the finite element analysis used for the testing part with the 
Ansys Workbench software will be described. Moreover, the devices will be 
presented, along with its main parameters. Also, will be described the set-up of the 
experiments. 
 
2.3.1 Stent design  
 
As described before, the final devices design implemented for the realization of 
the two biodegradable stents present different characteristics. First, the design 
will be inspired from the two most used configurations: T-mesh and W-mesh. 
These configurations, as will be described in the next chapter, guarantee to have 
the necessary characteristics to be implanted in the vessel of the human body. 
Second, the devices section is circular, and this was due to fabrication 
requirements, the selected section is circular and not squared. In the following 
figure is possible to have a visual presentation of the devices and to notice the 
design differences described before. 
 
 
 
 
 
 
 
 
 
Figure 29 – Circular W stent   
 
 
 
 
 
 
 
 
Figure 30 – Circular T stent 
 
 
The W stent present alternating supports which connect the meshes. In this 
manner, the configuration gives stiffness to the device and can be printed with 
the 3D technique. In fact, in the first version designed, the supports were in the 
same longitudinal line, causing problems in the realization process. The T one 
has a grid mesh and the shape permits an easy fabrication process. 
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2.3.2 Model’s parameters  
 
From the analysis of the literature and to have a device that can be used for being 
adaptable to the patient exigences and for the characteristics that the device 
should possess, seven main parameters were fixed. All the measures of the stents 
structure depend from these values, which can be changed promoting an 
automatic updating of the model set up. In the following section the seven 
fundamentals parameters and the consequence caused by of their change are 
presented. The parameters are: 
 
• Diameter 
• Length 
• Thickness 
• Mesh Length 
• Mesh Width 
• Number of Length Mesh Repetition 
• Number of Radial Mesh Repetition  
 
 
2.3.2.1 Diameter 
 
The first parameter investigated is the diameter. This is fundamental for the 
application vessel in which the device has to be implanted. In fact, an artery 
vessel such as Aorta has a diameter that is bigger than a coronary one.  The 
example reported previously is connected to the blood vessels, but the field 
of application is wide, because the device can be used also for the tracheal 
conduct.  
 
 
 
 
 
 
 
 
 
Figure 31 – Diameter variation 
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2.3.2.2 Length  
 
The second parameter which is possible to change is the stent length. The 
number of the mesh remain the same but the mesh dimension changes. The 
parameter depends from the patient disease and adapting the correct length to 
the device the healing period will be faster, because the degradation time of the 
stent will be the correct one and the damages caused by the insertion of the 
device involves a less part of the vessel. Having this possibility, the advantage 
for the production process is to save material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32 – Length variation 
 
 
2.3.2.3 Thickness 
 
In the literature it is stated that for metallic stent, the strut thickness commonly 
used is 0.1 mm. For biodegradable stents, the thickness is usually larger due 
to the material and the consequent resistive capacity (0.3 - 0.5 mm). This 
parameter can be changed to satisfy this limitation and to adapt the stent to 
several materials. In fact, is possible to tests the device with the different 
thicknesses to use the best one which guarantee the mechanical features and 
the necessary degradation time in order to preserve the healing period. Is not 
possible for the biodegradable stents to have thickness less of 0.3 mm. On the 
contrary, a thickness larger than the 0.5 mm is not useful for the medical 
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application. The stent design implemented in the devices can be used with a 
widely range of materials.  
 
 
 
 
 
 
 
 
 
 
Figure 33 – Thickness variation 
 
 
 
2.3.2.4 Mesh Length 
 
In the development of a new stent another important parameter is the mesh 
length. Modifying this value, there is the variation of the size of meshes in a 
longitudinal direction. Consequently, the number of meshes changes and the 
mechanical properties of the device are different and new. The most 
important one is the radial stiffness. The stent implanted has to resist to the 
compression rate imposed by the hearth activity which reflects in the 
movements of the vessels wall. For this reason, it is important the study of 
the variation of this parameter. One of the goals of the present work is the 
analysis of the devices involved in the variation of the parameter, mostly in 
the field of the compression test. 
Modifying the length of the single element of the mesh, all the parts forming 
the cell are automatically adapted to the new measure. This is useful if the 
vessel disease tract has a particular trend or if has a very small diameter and 
is necessary to change the properties of the stent. From the following figure 
is possible to understand how in the same vertical length the cell dimension 
is changed. In fact, in the upper part there are two meshes in the longitudinal 
direction instead below there is only one cell. But the longitudinal dimension 
the length value is the same.  
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Figure 34 – Length mesh variation 
 
 
2.3.2.5 Mesh Width  
 
Another parameter is the mesh width. In fact, is possible to change the 
parameter maintaining the same diameter of the device. This influences the 
mechanical properties of the stent such as the flexibility and the radial force. 
Also, in this case, changing the width of the single cell is an improvement for 
the medical application, because the device is able to follow better the trend 
of the vessel. Moreover, due to the wide field of application, the stent should 
be capable of adapting to different situations. It is important to analyze the 
effects deriving from the variation of this value. Further studies could be done 
to investigate this topic. In this work the focus was on the radial stiffness tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35 – Length width mesh variation 
 
 45 
2.3.2.6 Number of Length Mesh Repetitions 
 
Another useful parameter in the definition of the stent structure, is the number 
of the mesh repetition in the longitudinal direction. In fact, is possible to 
change this parameter maintaining fix the device length. In fact, to guarantee 
acceptable mechanical properties, and considering the small thickness of the 
device and the functions that have to do, is fundamental the possibility to 
augment the number of the mesh repetitions. Augmenting the value of the 
parameter, will be present more meshes in the same place. This cause an 
increase of the stent material in the vessel and consequently the degradation 
time will be longer. A determinate value has to be found. In fact, the desired 
mechanical properties have to be maintained and the correct degradation time 
has to be researched. The figure, is possible to have a visual presentation on 
how the parameter influences the struct of the stent, having the same 
longitudinal length. Unavoidably, the dimensions of the single mesh are 
optimized for the parameter choice.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                Figure 36 – Number of Length Mesh Repetition 
 
 
 
2.3.2.7 Number of Radial Mesh Repetitions  
 
The last parameter chosen and described is the Number of Radial Mesh 
Repetition. As for the number of Length Mesh Repetition, it can influence the 
mechanical properties of the stents, in particular the radial stiffness of the 
device. In fact, augmenting the mesh cells in the circumference direction of 
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the stent, there is a higher maximum radial stiffness value. This can be proved 
touching a physical realization of the device. The number of elements is 
chosen considering shape of the vessel involved in the disease. In fact, vessels 
with twisted shapes need a very flexible device which follow the development 
of the tube. On the contrary, for “linear” shapes can be chosen more rigid 
devices. More element will be present, more the vacuum spaces will be 
inferior, causing a less presence of in stent restenosis. All the measures, when 
the parameter changes, are immediately adapted ad optimized, using the 
relationship functions implemented for the parametrization of the stents 
created. In the figure, is possible to understand better how, changing the 
parameter, the structure modifies its design. The blue device has a smaller 
number of elements in the radial dimension than the red one, but they have 
the same diameter, thickness and length. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37 – Number of Radial Mesh Repetition 
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2.3.3 Finite Element Analysis  
 
The Finite Element Method (FEM) is applied to susceptible physics bodies at 
the division into a certain number of elements with a definite shape and a limited 
dimension. In the continuum, each component is considered a numeric 
integration field with homogenous features. The main characteristic is the 
discretization process throw the mesh creation, composed by primitive shapes. 
For each element the problem solution is done from the linear combination of 
functions, named “shape functions” [17]. To arrive to the FEM, is necessary to 
follow a specific process: 
 
• Modeling is the first step. There is the passage from the physic system to 
the mathematic one. In this way, there is the abstraction of some 
important features, focusing into a smaller number of variables. The 
model choice influences the presence or absence of an error and to 
quantify it, experimental test has to be done.  
• Discretization: in a simulation process is necessary to limit the number 
of the degree of freedom (DOF). In fact, in the continuum the DOF in 
the space or in the time are infinite, but in the simulation process, has to 
be few. In this manner, an error is introduced and can be valuated with 
an adequate mathematic model of the structure.  
 
Each element can be 1D, 2D or 3D. The nodes are particular points which 
indicate the geometry [18]. At the nodes are connected joint reactions or 
displacement values. The number of this values for each node are the degree of 
freedom and for each node are present external forces or the joint reactions. 
Moreover, exist a linear relationship between the forces and the joint reactions: 
the “u” indicates the DOF vector and the “f” the external forces vector on one 
node.  
The equation is:  
 
K*u=f 
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Where the K is named stiffness matrix. The K*u value is the work done by the 
external forces. The last concept that has to be explained is that of constitutive 
features which is the description of the element property and its behavior [18].   
 
2.3.4 Radial stiffness evaluation 
 
The simulation part involves the studies of the radial stiffness. In fact, from the 
literature there is a lot of research in the field of the force for the stent insertion 
in the catheter, and studies of the expansion phenomenon when the device is 
placed in the blood vessel. But on the radial force exterted by the vessel on the 
stent and vice versa little is known. There are not upper or lower bounds in which 
the stent has to stay. The experiments that we did, are concentrated in the 
analysis of the two types of stents made by the two different materials described 
before and a comparison of them. In the next chapter, will be presented the initial 
configurations with the choices done, the obtained results and the final 
considerations.  
 
 
2.3.5 Set up of the computations  
 
All the tests for the numerical simulations for the study were done using the 
Workbench of Ansys. As described before the program was connected with 
SolidWorks and in this manner, it was possible to optimize the device projects. 
On the workbench it was selected the Static Structural panel and to simulate the 
radial stiffness, we created a of cylinder, with a length dimension 2 times bigger 
than the device one, with a thickness of 0.5 mm, made by Structural steel, to 
avoid deformation, which represents a typical artery vessel with a diameter of 5 
mm. Below, two different perspectives of the “vessel”- stent configuration are 
presents.  
 
 
 
 
 
 
 
 
 
Figure 38 – Model of blood vessel 
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Figure 39 – Frontal and ¾ visions 
 
 
A sliding contact is imposed between the device and the cylinder surfaces.  
The values used for the meshes were: 0.0001 [m] for the stent and one of 
0,0002 [m] for the cylinder. With these values the obtained results had an 
acceptable precision and the computational cost was reduced.  
 
 
 
 
 
 
 
 
 
 
Figure 40 – mesh modeling  
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Table 7 – number of mesh elements  
 
 
2.3.5.1 Radial Compression displacement imposed 
 
the stent was compressed and expanded by means of the cylinder [19]. In fact, 
were imposed to the internal surface of the vessel, the following range of 
displacement values: 
 
0 5 10 15 20 
15 10 5 0 
 
Table 7 – % values of the initial diameter of the stent 
 
The applied values are the percentual values related to the initial diameter of 
the structure, or rather 5 mm. The displacement is applied along all the inner 
surfaces of the cylinder at the same time [20]. In the following figure is 
possible to see how the displacements were applied [21]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41 – direction of the displacement application 
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The procedure was applied for the two types of stents, each one made by PCL 
or magnesium alloy AZ31. The evaluated radial force of both materials was 
finally compared. 
 
2.3.5.2 Material properties used  
 
As described before, in the engineering data of the workbench were inserted 
all the parameters necessary to define the material characteristics. For the 
PCL the required structural properties were Young’s modulus and Poisson’s 
ratio, having respectively the values of 400 MPa and 0.33. For the Magnesium 
alloy AZ31, a stress-strain curve was provided. The latter was extracted by 
literature data [Grogan et all, journal of the mechanical behavior of 
biomedical materials 12 (2012)]. the required features were the Young’s 
modulus of 44 GPa, the Yield strength of 138 MPa and the stress-strain 
values, which are reported in the following table, where in the left part are 
present the strain values in mm and in the right the stress values in MPa. 
 
 
 
 
 
 
 
 
 
 
Figure 42 – Material properties for blood vessel 
 
 
 
 
 
 
 
 
 
Figure 43 – Material properties for PCL Stent 
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Figure 44 – Material properties for AZ31 Alloy Stent 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8 – stress-strain tabular values 
 
 
 
 
 
 
 
Strain 
(mm) 
Stress 
(Mpa) 
0 0 
0.0012 41 
0.0018 72.8152 
0.00365 107.1412 
0.0042 140.1415 
0.0131 159.1796 
0.0239 175.4517 
0.0373 195.7952 
0.0474 212.0804 
0.0659 222.6965 
0.0812 230.629 
0.0977 239.9098 
0.1149 245.0537 
0.1327 246.0606 
0.148 248.4946 
0.1608 248.2319 
0.1735 250.7185 
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2.3.5.3 Boundary condition  
 
The initial and final ring of the cylinder were blocked to avoid a movement 
of the entire structure during the tests. The forces were applied on the internal 
surface of the cylinder. The decrease of the diameter was progressive and the 
solution method for the contact area was, for the stents made by elastic-linear 
material, MPC, instead, for the devices made by the elastic-plastic alloy, was 
the Augmented Lagrange, which permits a nonlinear behavior. 
 
 
 
 
 
 
 
 
 
 
Figure 45 – Fixed support in the external rings 
 
 
2.3.5.4 Force evaluation  
 
To obtain a force measures we had to take as the output of the computations 
the average Normal Stress in the longitudinal direction along, in this case, the 
Y axis of the coordinate system, which was positioned along the stent axis. 
The measures were expressed in megapascal. The normal force was estimated 
using the stress field computed during the compression/expansion and the 
area of the stent [22]. 
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2.3.6 Test procedure 
 
In this section, the entire process is summarized by means of a block-structured 
workflow. The software used for these objectives are Ansys 2019 and Matlab 
R2017b. With the diagram is easier to have a complete scheme about all the 
operations which have to be done. 
 
 
 
Diagram 1 – Radial compression test procedure  
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Chapter 3 
 
 
 
RESULTS AND DISCUSSION 
 
In the next paragraphs are presented the results obtained from the radial 
compression tests and a discuss about the analysis of the data calculated. The 
thickness used are 0.3 and 0.5 [mm]. Only one ring of meshes was used and a 
circular section was employed.   
 
3.1 Thickness limits  
 
The chosen thickness for the stent is derived from a limitation imposed by the 3D 
printing technique. In fact, the NAITEC industry guarantees to be able to produce 
the devices with at least a thickness equal to 0.4 millimeters. The lower limit 
deriving from the literature for biodegradable stents was of 0.3 mm and the upper 
one was of 0.5 mm. For this, we realized the 0.4 [mm] device, but it was decided to 
analyze and to test the devices with the limited thickness found in the literature to 
have a complete knowledge about the behavior of these stents. In fact, the 
fabrication technique can be improved in the next future, because the 3D printing 
is a recent process which have to still be completely studied and analyzed. The 
behavior of the devices with the thickness imposed by 3D printing process has to 
be considered as the average trend of that of the upper and lower bounds.  
 
 
3.2 Number of length mesh repetition 
 
All the devices studied for the analysis and the comparison have only one ring of 
meshes in the length. The reasons are: 
 
• The first, and the most important, is that there are no significative 
differences in the behavior between the devices with one or more ring of 
meshes for the radial compression test were found. This derives for the 
relatively small dimension of the meshes and the influences of the number 
changes little in the final value measured.  For other kind of trials such for 
example the flexibility tests, it become very important.  
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• The second, derives for reducing the computational costs and perform more 
cases. In fact, to preserve the simulation time there was the need to limit the 
number of elements in the finite element analysis. 
• The third, to have a sort of equilibrium and parallelism between the devices 
struct and configuration for comparison purpose between the two 
configurations. 
 
 
3.3 Struct limit 
 
As discussed, the strut section used in this work is circular. In fact, this was another 
limit imposed by the fabrication process. The project has the objective to arrive at 
the final stent with all the properties fixed and for this motivation the decision to do 
simulation trials only on the devices having the correct structure which was 
effectively useful for the development of the final stent. However, the square 
section was also tested. The presence of sharp angles causes an increasement of the 
local tensions measured in the stent during the compression dilatation process. 
 
Is also important to do not forget that the objective of the regional project PC086-
087-088 CONDE, financed by the Department of Economic Development of the 
Navarra Government, is to arrive to have a specific design to be produced and 
fabricated. For this reason, specific analyses were performed for analyzing all 
possible characteristics. 
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3.4 W mesh stent test results  
 
The W mesh stent test presents a very interesting results: in fact, from the simulation 
software it is possible to see some increase of tensions in specific region of the 
device, where the geometry is more complex. In the compression part of the trial in 
the places where are presents curves, discontinuities, configurations more 
difficulties, are measured the higher stress values. The differences between the 
initial configuration and that one with the biggest displacement imposed are clearly 
discernable. In the figures below, are presented the distribution of the normal 
stresses along the devices in the initial and in the most compressed configurations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 46 – 0% compression value 
 
 
The figure describes the normal stress values measured along the Y axis in the 
configuration where the displacement imposed is the 0% of the initial diameter of 
the device. In fact, the measures are very low and is also possibly to see a minimal 
difference between the parts with a linear geometry and that one with a more 
complex trend.  
From the initial configuration to the most compressed one is possible to notice the 
increase of the stress values along all the structure, but the higher values, which are 
represented with the red color, are visible only in specific only in some specific 
regions. The compression displacement imposed and shows in the next figure is the 
20% of the initial diameter which was of 5 mm. In fact, the tests were done 
simulating a typical artery vessel, that is the main application of the developed 
stents. 
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Figure 47 – 20% compression value 
 
 
The normal stress measured are so different from the previous image and the values 
are significative higher. In fact, more increase the compression displacement, more 
the different parts of the stent are closed, and as a result, it is produced an increase 
of the stress values in the regions where the geometry is more complex. The 
phenomenon is the same whatever is the material which compose the device. To 
understand the variations, it is necessary to plot the data measured with the same 
axes. The next step was to use Matlab to represents the values and to analyze the 
results obtained. Now, will be presented the differences in the behavior between the 
two devices with the same mesh design, but made by two difference materials.  
 
 
3.4.1 Linear-Elastic W-mesh comparison 
 
Firstly, using the strut diameter of 0.3 and 0.5 mm and the same design, the 
characteristics of the two materials were compared. In the Y axis are reported 
the normal stress measured and the X one, the diameter values are presented. In 
the figure, the points represent the values obtained and the line is their 
interpolation. The slope of the curves can give an idea of the different stent 
stiffness.  
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Figure 48 – W-mesh PCL device data  
 
 
From the figure is possible to do some important comments. Firstly, the load and 
unload process follow the same way. In fact, being an elastic-lineal material, the 
present behavior was expected. The maximum compression value is not so high 
and for this reason will not arrive to the limit. This is important for the patient 
application and means that the device can be compressed until to have the 
diameter of 4 mm in safe conditions. Also, after the compression, the device will 
return back to the initial condition without having damages to the structure and 
ready for a next compression test. The thickness influences the normal stress 
values, and as it was expected, increasing its value in the device we obtain that 
the forces measured are higher for the normal stress compression, but the 
behavior for the devices does not change. To have a value for the analysis can 
be used the maximum normal stress result measured or the slope of the curves 
and measures the ratio.  
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3.4.2 Elastic-Plastic W-mesh comparison 
 
The second analysis for the W-mesh device was done with the elastic-plastic 
material, or rather the Magnesium alloy AZ31, with the limit values of thickness, 
i.e. 0.3 mm and 0.5 mm. In the Y axis are reported the normal stress measured 
and the X one, the diameter values are presented. 
 
 
Figure 49 – W AZ31 device data  
 
 
The loading and unloading processes follow different ways. In fact, as expected, 
the compression requires a higher force than the expansion. The radial 
compression and expansion do not follow in fact the same curve. Moreover, is 
possible to see the residual deformation. In fact, at the diameter of 4.8 mm, there 
is a change of force trend with a new increase. In the normal condition, the 
experiment finish in that value, but considering that in the boundary conditions 
we imposed the slider contact between the vessel and the device, there is a 
constriction caused by the cylinder that causes the arrive at the final of the trial. 
It is necessary an additional force to bring the stent back to its initial 
configuration. Also, in this case, increasing the thickness of the stents it will have 
a higher force necessary for the compression Finally it is possible to see that an 
increase in thickness promotes an increase of the area of hysteresis. Moreover, 
is possible to notice that the area of the device with the smaller thickness is 
included almost totally inside that with the bigger thickness. 
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3.5 T mesh stent test results  
 
Observing the figure below is possible to see the differences between the two types 
of devices. In fact, the new configuration of this stent permits to have a lower 
normal stress values both for the initial and final configuration. Also, in this 
configuration, the presence of discontinuities in the design and a rapid change of 
direction causes the increase of the normal stress values. Moreover, also in this trial 
we decided to use a interval of compression values between 0% and the 20% of the 
initial diameter of the device which is 5 mm, equal to that used before.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50 – 0% compression value 
 
 
The tension values measured in the initial condition are a slightly higher than 
which detected before with the other configuration. Also here, there is a minimal 
difference of the elements with a complex geometry compared to the rest of the 
stent. The values measured are the normal stress along the Y axis. The following 
figure describes the forces detected at the moment of maximum compression, or 
rather when the diameter of the stent was of 4 mm. The red zones represent the ones 
in which the tensions are higher. 
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Figure 51 – 20% compression value 
 
 
Only considering the visual comparison is possible to understand that with the T 
mesh stent, the normal stress distributions detected are less than the one described 
above with the other mesh design typology of stent. In fact, the red zones are smaller 
and located only in the less points which present discontinuities. Moreover, the 
differences between the figure 51 and the figure 50 are very few. The necessity to 
have the same interval of the trial before is given by the necessity to have the same 
conditions to do the final analysis. Certainly, increasing the displacement value it 
can be arrived to have the color range close to that one of the before trial. The visual 
analysis is only a superficial method to have the first knowledge about the regions 
in which will be present the higher tension and which can be different from that 
ones expected. The qualitative information that can be extracted from the Figures 
can be quantified again using MatLab. In the figure is not present the cylinder which 
simulates the blood vessel. This was done to have a better view on the entire device.  
In the following section the numeric results obtained and an analysis between the 
behavior of the devices with the two limit thicknesses with two different materials 
will be presented. 
 
 
3.5.1 Linear-Elastic T-mesh comparison 
 
The third analysis presented is that one related to the behavior of the stents with 
T meshed fabricated with PCL material. The devices used have a bound value 
of thickness which are 0.3 mm and 0.5 mm. In the Y axis are reported the normal 
stress measures and the X axis, the diameter values are presented.  
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Figure 52 – T PCL device data  
 
For this configuration and for this case, the behavior of the two devices is as 
expected. In fact, they present a linear-elastic trend and follow the same 
trajectory for the loading and unloading process. As expected, the device with a 
thickness of 0.5 mm needs higher normal forces to be compressed until the 20% 
percent than the stent with the thickness of 0.3 mm. The behavior of the device 
with the realizable thickness, or rather of 0.4 mm will have a stiffness which 
slope lays between the lines represented in the two Figures. An important thing 
is that also for this configuration we are not arrived at the limit point. To have a 
value for the comparison can be used the maximum normal stress result 
measured or the slope of the curves and measures the ratio.  
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3.5.2 Elastic-Plastic T-mesh comparison 
 
For the last test presented, the analysis of the T device was done with the elastic-
plastic material (the Magnesium alloy AZ31) with the limit values of thickness, 
i.e. 0.3 mm and 0.5 mm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53 – T AZ31 device data  
 
 
In the figure are present the stiffness of the stents tested. The trend looks like 
that one of a linear-elastic material, but observing the central part is clearly 
distinguishable, easier for the device with the thickness of 0.5 mm, the 
differences between the trend during the loading process and that during the 
unloading one. It is possible to notice a slight hysteresis in the Figure. 
 
 
 
4 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 5
Diameter [mm]
0
1
2
3
4
5
6
7
8
9
10
Fo
rc
e 
[N
]
105 Normal Stress
T Thickness 0.5
T Thickness 0.3
 65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54 – Zoom on hysteresis area  
 
There is also the residual deformation, but the values now are very close to the 
initial diameter. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55 – Zoom on residual deformation  
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With the zoom on the hysteresis shown in the figure is possible to have an idea 
of the residual deformation, which is very small. It is possible to increase the 
testing interval, but to have a same condition for all the trials, we decided to stop 
the simulation at the 20%. Consequently, there would be a major hysteresis area, 
and the residual deformation would be bigger. 
 
 
3.6 Comparison between the T and W devices made by PCL 
 
Finally, all the presented computational results will be compared for having a 
general overview. 
 
Figure 56 – T and W PCL device data  
 
In the X axis of the plot are presented the different diameter correlated to the 
percentages presented in the methods part. In the Y axis are reported the Normal 
Force values measured. The force necessary to arrive at the limit compression value 
is bigger for the stents with the T mesh design. All the stents have the same trend 
in the loading and unloading process and the normal stress values are in the 1000-
10000 N interval. The comparison allows to understand how the design of the 
device can influence the mechanical behavior of the stent. The limit of the 
compression values imposed, in this case, is sufficient to have differences between 
the behavior of the stents with the two types of meshes, but to obtain a complete 
knowledge about their mechanical features could be important to compress the 
devices until the breaking point.  
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3.7 Comparison between the T and W devices made by AZ31 
 
The comparison between the behavior of the two typologies of devices made by the 
same elastic-plastic material, the Magnesium alloy AZ31, is very interesting.  
 
 
Figure 57 – T and W AZ31 device data  
 
 
From the figure is possible to notice how the devices with the T mesh have a more 
rigid behavior in the radial compression trials. In fact, to arrive at the final diameter 
of 4 mm, is necessary a higher force than the stents having the W mesh. The 
differences between the two typologies of design are very evident although are 
made with the same elastic-plastic material. It is incredible how the design can 
influence the presence of the stress values. The choice can be done also considering 
the place where the stent has to be implanted, or rather thinking about the diameter 
of the vessel, its conformation and the entity of the disease. Also, in this case, we 
are not arrived at the limit point of the devices. The T mesh device with the 0.3 mm 
has a mechanic behavior which is similar to the W mesh devices, because the 
maxima forces measured are very close, but there is a significative difference with 
the stent having a thickness of 0.5 mm and a T mesh. Its radial resistance is so high 
and probably the best choice could be to use a device with the intermediate 
thickness value, or rather of 0.4 mm. To have a better mechanical property for the 
W mesh there are the possibilities to increase the thickness of the stent, but in this 
case is not useful, because could not be used or could have a very limited range of 
application or changing the length of a single ring of meshes. It was important the 
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comparison done, because was possible to understand the differences between the 
two typologies of devices implemented.  
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3.8 Final considerations 
 
The results obtained from the realization of the thesis permit to have a parametric 
tool which allows the design of a stent. In particular, in this framework is possible 
to modify the device only changing the value of the desired parameter. The 
parametric tool was created for analyzing different types of device so that every 
change on a specific parameter directly modifies the geometry. In this way, either 
is possible to study the effect of each single parameter on the stent performances 
such as the radial compression stiffness. 
The final goal of this work is the design and optimization of a new prototype of 
stent which has to be made by a biodegradable material and has to be fabricated 
with a 3D printing technique [23]. The created parametric tool allows the analysis 
and computation of the stent structure and the numerical simulations that provide 
its main performances. The materials used were biodegradable and the realization 
process was obtained with a 3D printing technique.  
The effects obtained augmenting the thickness are an increase of the force necessary 
for the radial compression of the devices.  
The T-type, in the same conditions resulted more rigid than the W-type. In the work, 
two different biodegradable materials are used: the PCL which has a linear-elastic 
behavior and the Magnesium alloy AZ31 which behavior is elastic-plastic. Finally, 
the field of application of this new type of stent is very wide, because the device 
should be used for all the organs which presents a lumen. For this reason, the lumen 
diameter and stent length are two of the parameters defined in the structure among 
others.  
This allows lastly a patient specific personalization of the device. 
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3.9 Future improvements  
 
In the feature will be possible to have the definitive material properties and a new 
type of trial which permit to have a complete knowledge about the potentialities of 
the devices. Certainly, will be present an optimization of the design, improving the 
parameters exposed before to satisfy all the characteristics deriving from the 
fabrication process. Also, there will be the improvements of the factory realization 
method which consequently will involve another requirement. The next step will 
be the degradation test which will be conducted by the NAITEC company and the 
in vivo trials before to test the devices in the humans. In the end, the last passage 
will be the final production of the device.  
Below there is a diagram containing all the future improvements which are yet 
established. In the future, having the properties of the material used, it is possible 
to evaluate, in the T-type with 0.4 mm thickness of the strut, which are specific 
imposed, the effect of the various parameters and according to the application, to 
generate the final prototype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagram 2 – Future improvements process  
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